Aug 2026· IEEE journal of biomedical and health informatics· Vol PP, pp. 1-14· 0 citations
Medicine
TL;DR
Results indicate that stage-consistent integration of evolutionary profiles can improve PLM-based Acr prediction and support the prioritization of low-homology Acr candidates.
Abstract
Anti-CRISPR (Acr) proteins are natural inhibitors of CRISPR-Cas systems and are important regulators for controllable genome-editing applications. However, their computational identification remains challenging because Acrs are sequence-diverse, weakly conserved, and supported by limited labeled data. Here, we present AcrPLMEvo, a two-stage framework that integrates protein language model (PLM) representations with PSSM derived evolutionary profiles for low-homology Acr prediction. We systematically compared four representative PLM backbones, parameter-efficient adaptation strategies, and alternative PSSM-coupling routes. Evolutionary profiles were not universally beneficial; instead, their effects depended on both PLM backbone and the stage at which they were incorporated. A key finding was that evolutionary information was more consistently beneficial when retained at the downstream decision stage than when used only during PLM adaptation. Guided by this observation, AcrPLMEvo combines PSSM-aware DoRA adaptation of ESM-2 with frozen feature extraction and final-stage evolutionary feature reintroduction. In the matched benchmark comparison, AcrPLMEvo achieved the best overall performance among competing Acr predictors, with an AUC of 0.965 and an AUPRC of 0.778. Its predictive reliability was further supported on an independently curated external set of 44 proteins, where it correctly classified 41 proteins and produced no false positives. These results indicate that stage-consistent integration of evolutionary profiles can improve PLM-based Acr prediction and support the prioritization of low-homology Acr candidates.
Clinical use of CRISPR-Cas proteins for genome engineering is constrained by their large size, limiting in vivo delivery. To address this, we engineered an ultracompact and versatile platform from a minimally active, 400-amino acid Cas12f protein from Blautia lenta. A multi-stage strategy of structure-guided protein mu...
Dongkyeong Kim, Chia-Wei Huang, Richard Pan et al.· Molecular Therapy: Nucleic A...· 0 citations
Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated (Cas) proteins play a vital role in prokaryotic adaptive immune systems, defending against foreign genetic material. However, the classification of CRISPR-Cas systems remains challenging due to limited direct identification te...
Ning-Yi Zhang, Yu-Feng Zhao, Chen-Han Luo et al.· BMC Bioinformatics· 0 citations
EPIC, the Eukaryotic Promoter and transcription Initiation prediction Challenge, relies on understudied animals spanning three phyla: octopus, oyster, milkweed bug, Indian meal moth, and shark and is open to everyone.
Ilya E. Vorontsov, N. Gryzunov, Bayley R. McDonald et al.· bioRxiv· 0 citations
It is demonstrated that integrating protein language model-assisted filtering with structure-guided rational design provides an effective strategy for engineering PspCas12f1 and may facilitate the optimization of additional compact CRISPR nucleases.
Jing-Tong Liu, Sheng-Zhou Wang, Bei Wang et al.· Molecular Therapy· 0 citations
Recent discoveries of non-CRISPR RNA-guided nucleases have expanded the landscape of programmable genome editing beyond canonical Cas systems. Among these, TnpB proteins derived from IS200/IS605-family transposable elements are ultra-compact RNA-guided DNA endonucleases with potential for delivery-constrained genome en...
Bin Ma, Yi-Miao Li, Dong-Sheng Zhang et al.· Frontiers in Genome Editing· 0 citations
Cas9 nucleases of CRISPR-Cas adaptive immune systems are programmable RNA-guided DNA endonucleases that evolved from the transposon-associated IscB enzymes. Comparative structural studies have revealed substantial architectural elaboration during this evolutionary transition, including the replacement of the larger ωRN...
O. Nureki, K. Onishi, Yuta Shuto et al.· Research Square· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.